Topical Diclofenac, an Efficacious Treatment for Osteoarthritis: A Narrative Review Frédérique Bariguian RevelMarina FayetMartina Hagen Review Open access 21 February 2020 Pages: 217 - 236
The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review Juan D. CañeteJose Antonio Pinto TasendeRubén Queiro Review Open access 08 April 2020 Pages: 237 - 257
Review Article: Is Wnt Signaling an Attractive Target for the Treatment of Osteoarthritis? Rik J. LoriesSilvia Monteagudo Review Open access 10 April 2020 Pages: 259 - 270
Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review Giacomo Dal BelloPaolo GisondiGiampiero Girolomoni Review Open access 18 April 2020 Pages: 271 - 285
Depression in Psoriatic Arthritis: Dimensional Aspects and Link with Systemic Inflammation Ashish J. MathewVinod Chandran Review Open access 22 April 2020 Pages: 287 - 300
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study Ennio LubranoFabio Massimo PerrottaAntonio Marchesoni Original Research Open access 15 February 2020 Pages: 301 - 310
Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data Hirohito ShimizuHisanori KobayashiYutaka Ishii Original Research Open access 29 February 2020 Pages: 311 - 325
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial Roy FleischmannDaniel E. FurstRichard Brasington Original Research Open access 17 March 2020 Pages: 327 - 344
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic Jennie H. BestSteven C. VladIbrahim Abbass Original Research Open access 29 March 2020 Pages: 345 - 355
Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry Dimitrios A. PappasTaylor BlachleyJoel M. Kremer Original Research Open access 30 March 2020 Pages: 357 - 369
Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany Klaus KrügerGerd Rüdiger BurmesterMatthias H. Thomas Original Research Open access 17 April 2020 Pages: 371 - 382
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians Emma SullivanJim KershawSusan Boklage Original Research Open access 21 April 2020 Pages: 383 - 400
Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases Hermine LeroiValérie BadotChantal Roggeman Original Research Open access 02 May 2020 Pages: 401 - 413
Use and Switching of Biologic Therapy in Patients with Non-Radiographic Axial Spondyloarthritis: A Patient and Provider Survey in the United States Atul DeodharDavid SandovalTheresa Hunter Brief Report Open access 23 April 2020 Pages: 415 - 423
